A PHASE I STUDY OF HCW9218, A BIFUNCTIONAL TGFb ANTAGONIST/IL-15 PROTEIN COMPLEX, IN ADVANCED SOLID TUMORSJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62022-11-070OA
SYNERGISTIC APPROACH TO OVERCOME THE SOLID TUMOR MICROENVIRONMENT OF MESOTHELIOMA WITH NATURAL KILLER CELL-FOCUSED IMMUNOTHERAPYJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62022-11-070OA
TRI-SPECIFIC KILLER ENGAGERS TARGET NATURAL KILLER CELLS TOWARDS MESOTHELIOMAJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62022-11-070OA
ENHANCING NK CELL FUNCTION IN THE `COLD' TUMOR MICROENVIRONMENT OF PROSTATE CANCER WITH A NOVEL TRI-SPECIFIC KILLER ENGAGER AGAINST PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA)JOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62022-11-070OA
OFF-THE-SHELF, ENGINEERED IPSC-DERIVED NK CELLS MEDIATE POTENT CYTOTOXIC ACTIVITY AGAINST PRIMARY GLIOBLASTOMA CELLS AND PROMOTE DURABLE LONG-TERM SURVIVAL IN VIVOJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62021-11-100OA
HYPOXIA REPROGRAMS NATURAL KILLER CELLS AND IMPAIRS THEIR THERAPEUTIC POTENTIALJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62021-11-100OA
GTB-3550 TRI-SPECIFIC KILLER ENGAGER TRIKE™ DRIVES NK CELLS EXPANSION AND CYTOTOXICITY IN ACUTE MYELOID LEUKEMIA (AML) AND MYELODYSPLASTIC SYNDROMES (MDS) PATIENTSJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62021-11-1017OA
IPSC-DERIVED NK CELLS MEDIATE ROBUST ANTI-TUMOR ACTIVITY AGAINST GLIOBLASTOMAJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62020-12-101OAAI
TARGETING PAN-TUMOR ASSOCIATED ANTIGEN B7H3 VIA COMBINATION OF TRI-SPECIFIC KILLER ENGAGER AND OFF-THE-SHELF NK CELL THERAPY ENHANCES SPECIFICITY AND FUNCTION AGAINST A BROAD RANGE OF SOLID TUMORSJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62020-11-092PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向